tm logo
REYLIN
Dead/Abandoned
ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE

failure to respond or late response

on 11 Jul 2022

Last Applicant/ Owned by

CITY WEST BUSINESS CAMPUS

DUBLIN

IE

24

Serial Number

90787838 filed on 22nd Jun 2021

Registration Number

N/A

Correspondent Address

Jeremy Blackowicz

Bausch Health Companies

400 Somerset Corporate Blvd.

Bridgewater NJ 08807

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

REYLIN

Pharmaceutical preparations and substances for diagnosis and treatment of oral disease, namely, periodontitis, oral mucositis and bone and soft tissue regeneration, Dental rinse for oral health, Medicated pharmaceutical preparations and substances for the treatment and prevention of gastrointestinal diseases and disorders in humans including constipation, hepatic encephalopathy, irritable bowel syRead More

Classification Information


Class [003]
Cosmetics and Cleaning Products


Non-medicated dermatologic substances and preparations, namely, moisturizers, creams, powders, gels, solutions, shampoos, sprays, swabs, washes, ointments, Non-medicated oral health substances preparations in the form of powders, creams, rinses for the treatment of periodontitis, mouth dryness, cold sores, mouth ulcers

Class [005]
Pharmaceutical Products


Pharmaceutical preparations and substances for diagnosis and treatment of oral disease, namely, periodontitis, oral mucositis and bone and soft tissue regeneration, Dental rinse for oral health, Medicated pharmaceutical preparations and substances for the treatment and prevention of gastrointestinal diseases and disorders in humans including constipation, hepatic encephalopathy, irritable bowel syndrome, opioid-induced constipation and ulcerative colitis, Medicated beverages, powders, and gels for colonoscopies and endoscopic procedures, Pharmaceutical preparations and substances to prevent and treat diabetes mellitus, epilepsy, migraines, anxiety and depression, chronic pain, headaches, psychiatric disorders, and rare diseases such as Wilson and Huntington's disease, diabetes mellitus, cardiovascular/angina, hyperammonemia, hormone deficiencies (endocrinology), cancer, otolaryngology, and urinary tract, lungs, heart infections and diseases, central nervous system disorders, neuromuscular conditions, vaginal disorders, Pharmaceutical preparations for treating allergic rhinitis and asthma, Pharmaceutical preparations and substances for the treatment of skin and nail conditions, namely, acne, psoriasis, onychomycosis, tinea pedis, actinic keratosis, rosacea and other dermatoses, fungal infections, topical antibiotics to treat atopic dermatitis, actinic keratosis, acne, rosacea, psoriasis, athlete's foot, nail fungus and other skin ailments, conditions and dermatoses, Vitamins and mineral supplements

Class [010]
Medical Instrument Products


Radio frequency medical devices for contracting skin, body sculpting, and soft tissue reconstruction in a non-invasive manner; Medical devices for aesthetic and therapeutic applications for the skin and its subcutaneous structures, namely, a device for delivering energy to the skin and its underlying tissues; Lasers and radio frequency devices for medical and aesthetic treatment; Medical devices, namely, medical instruments designed for the non-invasive removal of human body fat using an external energy source

Mark Details


Serial Number

No 90787838

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
22nd Aug 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
22nd Aug 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
22nd Aug 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11th Jul 2022ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
11th Jul 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
23rd Dec 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
23rd Dec 2021NON-FINAL ACTION E-MAILED
23rd Dec 2021NON-FINAL ACTION WRITTEN
20th Dec 2021ASSIGNED TO EXAMINER
16th Oct 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED